Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March-May 2020

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020..

We report off-label use patterns for medications repurposed for coronavirus disease 2019 (COVID-19) at 318 US hospitals. Inpatient hydroxychloroquine use declined by 80%, whereas corticosteroids and tocilizumab were initiated 2 days earlier in May versus March 2020. Two thirds of ventilated COVID-19 patients were already receiving corticosteroids during March-May 2020, resembling pre-COVID use in mechanically ventilated influenza patients.

Errataetall:

CommentOn: Open Forum Infect Dis. 2020 Dec 15;8(2):ofaa617. - PMID 33553472

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Open forum infectious diseases - 8(2021), 2 vom: 04. Feb., Seite ofaa616

Sprache:

Englisch

Beteiligte Personen:

Kadri, Sameer S [VerfasserIn]
Demirkale, Cumhur Y [VerfasserIn]
Sun, Junfeng [VerfasserIn]
Busch, Lindsay M [VerfasserIn]
Strich, Jeffrey R [VerfasserIn]
Rosenthal, Ning [VerfasserIn]
Warner, Sarah [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Comment
Journal Article
Medications
Repurposed
SARS-CoV-2
Trends

Anmerkungen:

Date Revised 10.11.2023

published: Electronic-eCollection

CommentOn: Open Forum Infect Dis. 2020 Dec 15;8(2):ofaa617. - PMID 33553472

Citation Status PubMed-not-MEDLINE

doi:

10.1093/ofid/ofaa616

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32116623X